AbbVie's Options: A Look at What the Big Money Is Thinking
AbbVie's Options: A Look at What the Big Money Is Thinking
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $195.0 for AbbVie over the recent three months. Deep-pocketed investors have adopted a bullish approach towards AbbVie (NYSE:ABBV), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ABBV usually suggests something big is about to happen.
资金充沛的投资者对摩根士丹利表现出看好态势，市场参与者不应忽略这一点。我们在Benzinga跟踪公共期权记录的过程中揭示了这次重大变动。这些投资者的身份仍未公开，但在ABBV股票通常出现如此大幅变动时，这通常意味着即将出现重要事件。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for AbbVie. This level of activity is out of the ordinary.
我们从今天的观察中获得了这些信息，当Benzinga的期权扫描器突出显示AbbVie的8种非凡的期权交易活动。这种活动水平是不同寻常的。
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $109,500, and 6 are calls, amounting to $402,314.
这些重量级投资者的普遍情绪有分歧，50%看好，50%看淡。在这些显著的期权中，有2个看跌，总额为109,500美元，有6个看涨，总额为402,314美元。
Expected Price Movements
预期价格波动
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $195.0 for AbbVie over the recent three months.
根据交易活动，显然主要投资者的目标价格区间为艾伯维公司在最近三个月内的150.0至195.0美元。
Volume & Open Interest Development
成交量和持仓量的评估是期权交易中的一个关键步骤。这些指标揭示了阿里巴巴集团（Alibaba Gr Hldgs）特定执行价格期权的流动性和投资者兴趣。下面的数据可视化了在过去30天内，阿里巴巴集团（Alibaba Gr Hldgs）在执行价格在74.0美元到120.0美元区间内的看涨看跌期权中，成交量和持仓量的波动情况。
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in AbbVie's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to AbbVie's substantial trades, within a strike price spectrum from $150.0 to $195.0 over the preceding 30 days.
评估成交量和持仓量是期权交易中的战略步骤。这些指标揭示了对艾伯维公司期权在特定执行价格的流动性和投资者兴趣。即将到来的数据可视化显示了过去30天内关于看涨和看跌的成交量和持仓量的波动，与艾伯维公司的大宗交易相对应，在150.0至195.0美元的执行价格范围内。
AbbVie Call and Put Volume: 30-Day Overview
艾伯维公司看涨和看跌成交量：30天概览
Noteworthy Options Activity:
值得注意的期权活动：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | TRADE | BEARISH | 11/15/24 | $14.95 | $14.65 | $14.65 | $180.00 | $99.6K | 1.6K | 69 |
| ABBV | CALL | TRADE | BULLISH | 10/11/24 | $12.85 | $12.05 | $12.61 | $180.00 | $87.0K | 76 | 69 |
| ABBV | CALL | TRADE | BEARISH | 01/16/26 | $28.2 | $27.9 | $27.9 | $180.00 | $80.9K | 408 | 29 |
| ABBV | PUT | TRADE | BEARISH | 02/21/25 | $11.45 | $10.1 | $11.45 | $195.00 | $68.7K | 598 | 0 |
| ABBV | CALL | SWEEP | BULLISH | 11/15/24 | $5.75 | $5.65 | $5.75 | $195.00 | $63.8K | 3.0K | 200 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 艾伯维公司 | 看涨 | 交易 | 看淡 | 11/15/24 | $14.95 | $14.65 | $14.65 | 180.00美元 | $99.6K | 1.6K | 69 |
| 艾伯维公司 | 看涨 | 交易 | 看好 | 10/11/24 | $12.85 | $12.05 | $12.61 | 180.00美元 | $87.0K | 76 | 69 |
| 艾伯维公司 | 看涨 | 交易 | 看淡 | 01/16/26 | $28.2 | $27.9 | $27.9 | 180.00美元 | $80.9K | 408 | 29 |
| 艾伯维公司 | 看跌 | 交易 | 看淡 | 02/21/25 | $11.45 | $10.1 | $11.45 | $195.00 | $68.7K | 598 | 0 |
| 艾伯维公司 | 看涨 | SWEEP | 看好 | 11/15/24 | $5.75 | $5.65 | $5.75 | $195.00 | $63.8K应该是指成交量为63,800股。 | 3.0K | 200 |
About AbbVie
关于艾伯维公司
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie是一家药品公司，其在免疫学（包括Humira、Skyrizi和Rinvoq）和肿瘤学（包括Imbruvica和Venclexta）方面拥有强大的业务。该公司于2013年初从Abbott分拆而来。2020年收购雅培使其在美容业务（包括Botox）中新增了一些产品和药品。
Having examined the options trading patterns of AbbVie, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在审查AbbVie的期权交易模式后，我们的注意力现在直接转向该公司。这种转变使我们能够深入探讨其现在的市场地位和表现。
Where Is AbbVie Standing Right Now?
艾伯维目前处于什么状态？
- Trading volume stands at 729,519, with ABBV's price up by 0.12%, positioned at $193.25.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 21 days.
- 成交量为729,519，艾伯维公司的股价上涨0.12%，定位在193.25美元。
- RSI指标显示该股票目前处于超买和超卖之间的中立状态。
- 财报预计在21天内公布。
Professional Analyst Ratings for AbbVie
AbbVie的专业分析师评级
2 market experts have recently issued ratings for this stock, with a consensus target price of $218.5.
最近，两位市场专家为这支股票发布了评级，一致目标价为218.5美元。
Turn $1000 into $1270 in just 20 days?
在短短20天内，将1000美元变成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on AbbVie with a target price of $225. * Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for AbbVie, targeting a price of $212.
20年期期权交易专家揭示了他的一行图表技术，显示何时买入和卖出。跟随他的交易，平均每20天获利27%。点击这里查看。* 在评估方面保持一贯性，TD Cowen的分析师继续对艾伯维公司给予买入评级，目标价225美元。* 保持立场，巴克莱银行的分析师继续持有对艾伯维公司的超配评级，目标价212美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期权与仅交易股票相比是一种更具风险的资产，但它们具有更高的利润潜力。认真的期权交易者通过每日学习，进出交易，跟随多个指标并密切关注市场来管理这种风险。
